Page last updated: 2024-08-23

pergolide and alpha-synuclein

pergolide has been researched along with alpha-synuclein in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hillman, R; Parvez, F; Pendleton, RG; Sayed, M1
Hirohata, M; Ono, K; Yamada, M1
Funakoshi, T; Iwata, S; Wakamatsu, M; Yoshimoto, M1

Other Studies

3 other study(ies) available for pergolide and alpha-synuclein

ArticleYear
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins

2002
Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
    Journal of neuroscience research, 2007, May-15, Volume: 85, Issue:7

    Topics: alpha-Synuclein; Antiparkinson Agents; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; In Vitro Techniques; Molecular Structure; Neurofibrillary Tangles; Pergolide; Polymers; Selegiline; Trihexyphenidyl

2007
Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Journal of neuroscience research, 2008, Feb-15, Volume: 86, Issue:3

    Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Exploratory Behavior; Humans; Levodopa; Male; Mice; Mice, Transgenic; Motor Activity; Parkinson Disease; Peptide Fragments; Pergolide; Receptors, Dopamine D2

2008